99 related articles for article (PubMed ID: 17132650)
1. Pretreatment with intracoronary adenosine reduces the incidence of myonecrosis after non-urgent percutaneous coronary intervention: a prospective randomized study.
Lee CH; Low A; Tai BC; Co M; Chan MY; Lim J; Lim YT; Tan HC
Eur Heart J; 2007 Jan; 28(1):19-25. PubMed ID: 17132650
[TBL] [Abstract][Full Text] [Related]
2. Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment.
Chen WH; Lee PY; Ng W; Tse HF; Lau CP
J Am Coll Cardiol; 2004 Mar; 43(6):1122-6. PubMed ID: 15028378
[TBL] [Abstract][Full Text] [Related]
3. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome.
Chang SM; Yazbek N; Lakkis NM
Catheter Cardiovasc Interv; 2004 Jun; 62(2):193-7. PubMed ID: 15170709
[TBL] [Abstract][Full Text] [Related]
4. Effect of myocardial protection of intracoronary adenosine and nicorandil injection in patients undergoing non-urgent percutaneous coronary intervention: a randomized controlled trial.
Kim SJ; Kim W; Woo JS; Ha SJ; Kang WY; Hwang SH; Kang DG; Lee SU; Cho SK; Im JS; Kim W
Int J Cardiol; 2012 Jun; 158(1):88-92. PubMed ID: 21256606
[TBL] [Abstract][Full Text] [Related]
5. [QT dispersion and myonecrosis after stent percutaneous coronary intervention].
Marazia S; Zimarino M; Torge G; Pasquale M; Caputo M; Floris F; Leonzio L; Di Iorio C; De Caterina R
Ital Heart J Suppl; 2004 Nov; 5(11):861-7. PubMed ID: 15633430
[TBL] [Abstract][Full Text] [Related]
6. Measuring aspirin resistance, clopidogrel responsiveness, and postprocedural markers of myonecrosis in patients undergoing percutaneous coronary intervention.
Buch AN; Singh S; Roy P; Javaid A; Smith KA; George CE; Pichard AD; Satler LF; Kent KM; Suddath WO; Waksman R
Am J Cardiol; 2007 Jun; 99(11):1518-22. PubMed ID: 17531573
[TBL] [Abstract][Full Text] [Related]
7. Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome.
Jia XW; Fu XH; Zhang J; Gu XS; Fan WZ; Wu WL; Hao GZ; Li SQ; Jiang YF
Chin Med J (Engl); 2009 Mar; 122(6):659-64. PubMed ID: 19323930
[TBL] [Abstract][Full Text] [Related]
8. Occurrence of non-Q wave myocardial infarction following percutaneous coronary intervention in the stent era: systematic monitoring of the three markers of myocardial necrosis.
Varani E; Balducelli M; Vecchi G; Gatti C; Lucchi GR; Maresta A
J Interv Cardiol; 2005 Aug; 18(4):243-8. PubMed ID: 16115152
[TBL] [Abstract][Full Text] [Related]
9. Impact of periprocedural myonecrosis on clinical events after implantation of drug-eluting stents.
Jang JS; Hong MK; Park DW; Lee SW; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
Int J Cardiol; 2008 Oct; 129(3):368-72. PubMed ID: 18035437
[TBL] [Abstract][Full Text] [Related]
10. [Study on the relationship between aspirin resistance and incidence of myonecrosis after non-emergent percutaneous coronary intervention].
Zhang Y; Liang J; Zhou YJ; Yuan H; Zhang YZ; Dong L
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Aug; 33(8):695-9. PubMed ID: 16188050
[TBL] [Abstract][Full Text] [Related]
11. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction.
Briguori C; Colombo A; Airoldi F; Violante A; Focaccio A; Balestrieri P; Paolo Elia P; Golia B; Lepore S; Riviezzo G; Scarpato P; Librera M; Bonizzoni E; Ricciardelli B
Eur Heart J; 2004 Oct; 25(20):1822-8. PubMed ID: 15474697
[TBL] [Abstract][Full Text] [Related]
12. Plaque volume and occurrence and location of periprocedural myocardial necrosis after percutaneous coronary intervention: insights from delayed-enhancement magnetic resonance imaging, thrombolysis in myocardial infarction myocardial perfusion grade analysis, and intravascular ultrasound.
Porto I; Selvanayagam JB; Van Gaal WJ; Prati F; Cheng A; Channon K; Neubauer S; Banning AP
Circulation; 2006 Aug; 114(7):662-9. PubMed ID: 16894040
[TBL] [Abstract][Full Text] [Related]
13. Aggressive statin therapy in multicenter and effectiveness for the reduction of intra-myocardial damage caused by non-ST elevation acute coronary syndrome: AMERICA study.
Hara H; Nakamura M; Yokouchi I; Kimura K; Nemoto N; Ito S; Ono T; Itaya H; Shiba M; Wada M; Iijima R; Yamamoto M; Yamamoto M; Hara H; Takagi T; Asahara T; Mitsuo K; Kobayashi N; Sugi K
Ther Adv Cardiovasc Dis; 2009 Oct; 3(5):357-65. PubMed ID: 19638365
[TBL] [Abstract][Full Text] [Related]
14. Naproxen treatment prevents periprocedural inflammatory response but not myocardial injury after percutaneous coronary intervention.
Ozdol C; Gulec S; Rahimov U; Atmaca Y; Turhan S; Erol C
Thromb Res; 2007; 119(4):453-9. PubMed ID: 17157900
[TBL] [Abstract][Full Text] [Related]
15. High post-treatment platelet reactivity is associated with a high incidence of myonecrosis after stenting for non-ST elevation acute coronary syndromes.
Cuisset T; Frere C; Quilici J; Morange PE; Nait-Saidi L; Mielot C; Bali L; Lambert M; Alessi MC; Bonnet JL
Thromb Haemost; 2007 Feb; 97(2):282-7. PubMed ID: 17264958
[TBL] [Abstract][Full Text] [Related]
16. Randomized trial comparing 600- with 300-mg loading dose of clopidogrel in patients with non-ST elevation acute coronary syndrome undergoing percutaneous coronary intervention: results of the Platelet Responsiveness to Aspirin and Clopidogrel and Troponin Increment after Coronary intervention in Acute coronary Lesions (PRACTICAL) Trial.
Yong G; Rankin J; Ferguson L; Thom J; French J; Brieger D; Chew DP; Dick R; Eccleston D; Hockings B; Walters D; Whelan A; Eikelboom JW
Am Heart J; 2009 Jan; 157(1):60.e1-9. PubMed ID: 19081397
[TBL] [Abstract][Full Text] [Related]
17. Direct coronary stenting versus stenting with balloon pre-dilation: incidence of enzyme release and follow-up results of a multicentre, prospective, randomized study. The CK and Troponin I Estimation in direct STenting (CK TEST) trial.
Balducelli M; Varani E; Vecchi G; Paloscia L; Manari A; Santarelli A; Cappi B; Shoeib A; Valenti S; Maresta A;
Minerva Cardioangiol; 2007 Jun; 55(3):281-9. PubMed ID: 17534246
[TBL] [Abstract][Full Text] [Related]
18. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention.
Ishii H; Ichimiya S; Kanashiro M; Aoyama T; Ogawa Y; Murakami R; Amano T; Naruse K; Matsubara T; Murohara T
Clin Ther; 2006 Nov; 28(11):1812-9. PubMed ID: 17213001
[TBL] [Abstract][Full Text] [Related]
19. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
[TBL] [Abstract][Full Text] [Related]
20. Effects of pretreatment with clopidogrel on nonemergent percutaneous coronary intervention after fibrinolytic administration for ST-segment elevation myocardial infarction: a Clopidogrel as Adjunctive Reperfusion Therapy-Thrombolysis in Myocardial Infarction (CLARITY-TIMI) 28 study.
Gibson CM; Murphy SA; Pride YB; Kirtane AJ; Aroesty JM; Stein EB; Ciaglo LN; Southard MC; Sabatine MS; Cannon CP; Braunwald E;
Am Heart J; 2008 Jan; 155(1):133-9. PubMed ID: 18082504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
